Your browser doesn't support javascript.
loading
Randomized Controlled Trials 2: Analysis.
Foley, Robert N; Parfrey, Patrick S.
Afiliação
  • Foley RN; USRDS Co-ordinating Center, University of Minnesota, Minneapolis, MN, USA.
  • Parfrey PS; Clinical Epidemiology Unit, Department of Medicine, Faculty of Medicine, Memorial University, St. John, NL, Canada. pparfrey@mun.ca.
Methods Mol Biol ; 2249: 213-227, 2021.
Article em En | MEDLINE | ID: mdl-33871846
ABSTRACT
When analyzing the results of a trial, the primary outcome variable must be kept in clear focus. In the analysis plan, consideration must be given to comparing the characteristics of the subjects, taking account of differences in these characteristics, intention-to-treat analysis, interim analyses and stopping rules, mortality comparisons, composite outcomes, research design including run-in periods, factorial, stratified and crossover designs, number needed to treat, power issues, multivariate modeling, subgroup analysis, competing risks, and hypothesis-generating analyses.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto Idioma: En Ano de publicação: 2021 Tipo de documento: Article